Urinary Tract Infections (UTIs) affect more than 152 million patients yearly and are, therefore, one of the most common types of diseases. Diagnostics of UTIs require time-consuming sample logistics and incubation by specialists in laboratories with high personnel costs (duration: 2-5 working days). As an initial treatment, patients are prescribed a broad-spectrum antibiotic until a more accurate infection assessment is available, leading to the development of multi-resistant germs. BugSense is a paper-based, patient-oriented solution combining cultivation and antibiotic resistance testing in one step, reducing testing time, costs, logistical effort, and especially unnecessary antibiotic prescriptions. The test should provide a user-friendly diagnostic and personalized treatment for anyone.

BugSense Diagnostics

Org chart

Teams

Offices

BugSense Diagnostics

Org chart

Teams

Offices

Related companies